Tscan Therapeutics Inc - TCRX - stock price prediction, stock price target, analyst ratings from 7 analysts

Tscan Therapeutics Inc has a share price target of US$ 6, revenue growth forecast of 278.7%, and profit growth estimate of -8.7% for FY25, based on top 7 analyst calls.